Gene Query: EMB

Dataset Description Geneva Score
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 65.87
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 63.48
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 57.01
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 55.54
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 51.68
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 50.39
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 50.17
Inhibition of TNBC metastasis by Gpx1 49.97
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 49.81
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 49.52
Effect of Hotair overexpression in human breast cancer cell lines 46.83
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 45.2
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 43.1
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 43.1
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 43.0
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 42.8
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 41.5
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 37.12
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 37.12
Depicting early human development and germ cell origin with porcine embryos 36.59
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 35.81
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 35.65
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 35.59
A transcriptome-wide divergence in protein translation scales with LIN28B expression 32.22
Transcriptome wide analysis of classically and alternatively activated macrophages 32.08
Downregulation of LATS kinases alters p53 to promote cell migration 31.83
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 31.8
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 31.79
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 30.84
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 28.98
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 28.24
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 28.1
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 28.1
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 27.86
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 27.52
Disruption of the exocyst induces podocyte loss and dysfunction 27.27
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 27.2
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 27.2
Fbxo32 mediated gene expression program underlies EMT and metastasis 26.97
LNCaP treated with iBET 26.53
RNA-seq analysis of AML cells in response to ASLAN003 26.46
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 26.15
Transcriptome of Stabilin-1 siRNA transfected human monocytes 25.63
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 25.15
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 25.09
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 25.0
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 24.56
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 24.56
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 24.56
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 24.44
Ebola virus (EBOV) infection of ARPE-19 cells 24.19
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 24.04
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 23.77
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 23.68
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 23.6
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 23.43
Landscape of H3K4me3 in human CD19 cells 22.37
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 22.27
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 22.18
Macrophage Ad5f35 M2 Challenge 21.86
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 21.53
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 21.53
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 21.52
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 21.42
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 21.31
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 21.13
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 21.05
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 20.94
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 20.59
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 20.18
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 20.06
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 19.97
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 19.8
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 19.69
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 19.44
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 19.41
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 19.41
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 19.41
Nucleoporin-mediated regulation of cell identity genes 19.3
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 18.96
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 18.96
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 18.93
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 18.91
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 18.91
Cleavage Factor Im as a key regulator of 3’ UTR length 18.89
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 18.57
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 18.54
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 18.5
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 18.44
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 18.42
MYCi975 regulates MYC target genes 18.36
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 18.25
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 18.12
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 18.07
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 18.02
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 17.93
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 17.88
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 17.88
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 17.84
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 17.84
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 17.73
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 17.73
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 17.53
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 17.34
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 17.22
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 17.07
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 17.07
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 16.93
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 16.93
RNA expression following TMPRSS11B overexpression or depletion 16.89
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 16.88
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 16.8
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 16.78
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 16.57
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 16.56
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 16.45
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 16.4
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 16.36
RNA sequencing with KSHV infection and enrichment for circular RNAs 16.31
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 16.21
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 16.07
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 15.95
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 15.8
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 15.64
Short and Long RNA sequencing of human mature erythrocytes 15.57
hTERT promotes cell adhesion and migration independent of telomerase activity 15.5
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 15.38
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 15.33
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 15.32
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 15.31
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 15.31
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 15.12
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 15.02
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 14.99
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 14.99
Primate transcript and protein expression levels evolve under compensatory selection pressures 14.93
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 14.85
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 14.74
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 14.69
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 14.69
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 14.67
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 14.67
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 14.57
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 14.54
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 14.54
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 14.43
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 14.43
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 14.41
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 14.41
Total RNA-seq in ALL-SIL upon JQ1 inhibition 14.36
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 14.21
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 14.09
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 13.99
Genetic-to-epigenetic Therapy for Pancreatic Cancer 13.86
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 13.71
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 13.67
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 13.36
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 13.36
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 13.36
IDH3a KO RNA-seq 13.3
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 13.3
Integrating single-cell transcriptomic data across different conditions, technologies, and species 13.3
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 13.29
Paxillin regulates genomic networks in prostate cancer [LNCaP] 13.26
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 13.15
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 13.09
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 13.06
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 12.9
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 12.89
Transcriptome analysis of H9 hESC derived cerebral organoids 12.85
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 12.85
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 12.85
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 12.78
RNA-Seq from early time points in the kidney differentiation protocol 12.68
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 12.66
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 12.63
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 12.63
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 12.61
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 12.61
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 12.48
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 12.44
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 12.44
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 12.22
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 12.09
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 11.98
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 11.98
Peptidomimetic blockade of MYB in acute myeloid leukemia 11.98
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 11.98
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 11.94
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 11.9
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 11.9
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 11.86
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 11.85
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 11.85
AR-independent prostate cancer is sustained through FGF signaling 11.85
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 11.84
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 11.83
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 11.73
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 11.7
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 11.7
A practical evaluation of alignment algorithms for RNA variant calling analysis 11.69
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 11.67
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 11.67
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 11.65
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 11.64
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 11.64
RNA-seq of resting and activated CD4+ T cells +-JQ1 11.6
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 11.51
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 11.47
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 11.44
Macrophage Ad5f35 PhenoMap 11.37
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 11.29
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 11.28
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 11.25
Trans-differentiation of human adult peripheral blood T cells into neurons 11.23
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 11.22
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 11.22
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 11.22
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 11.11
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 11.02
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 10.99
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 10.95
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 10.95
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 10.91
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 10.91
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 10.88
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 10.77
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 10.71
LncRNA expression profiling of ischemic stroke patients 10.51
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  10.46
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 10.43
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 10.42
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 10.41
Human cells contain natural double-stranded RNAs with potential regulatory capacity 10.39
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 10.35
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 10.33
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 10.29
Active translatome profiling with RiboLace in MCF7 cells 10.28
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 10.23
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 10.23
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 10.21
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 10.17
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 10.17
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 10.11
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 10.11
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 10.11
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.09
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.09
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 10.05
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 10.05
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 10.03
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 10.03
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 10.02
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 10.02
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 10.0
Transcriptome profiling of 5 human adenocarcinoma cell lines 9.97
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 9.86
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.85
Transcriptome-wide identification of CELF2 functional targets in T cells 9.73
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 9.65
Altering cancer transcriptomes using epigenomic inhibitors 9.65
circRNA profile in hypopharyngeal cancer 9.55
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 9.54
Transcriptional effect of ETV1 knockdown in melanoma cells 9.5
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 9.49
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 9.47
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 9.43
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 9.43
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 9.42
Gene expression changes in human melanoma cell lines compared to primary melanocytes 9.41
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 9.39
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 9.29
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 9.23
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 9.16
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 9.1
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 9.03
The effect of Abl kinases on non-small cell carcinoma global transcriptome 8.99
Transcriptome analysis of human lung epithelial cells 8.98
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 8.9
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 8.9
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 8.89
RNA sequencing of matched nephrectomy samples [RNA-seq] 8.73
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 8.73
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 8.72
Transcriptomes of human monocytes after ex vivo exposure to uric acid 8.69
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 8.64
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 8.62
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 8.57
Be1 and Be2 B cells are transcriptionally distinct 8.49
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 8.47
The transcriptome of Kawasaki Disease arteritis 8.36
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 8.33
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 8.28
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 8.27
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 8.27
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 8.27
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 8.18
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 8.1
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 8.05
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 8.05
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 7.99
SLIGRL-induced gene expression changes in NHEK cells 7.85
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 7.8
RNA-seq of naive and primed ES cells (NHSM) 7.75
BCL11B 7.74
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 7.64
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 7.61
The pioneer factor CEBPA modulates vitamin D signaling 7.61
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 7.5
CDK4/6 inhibitor resistance in prostate cancer 7.49
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 7.46
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 7.36
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 7.36
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 7.32
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 7.29
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 7.19
RNAseq of cell lines with knocked in ESR1 mutations 7.14
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 7.1
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 7.09
Global response to chemotherapy-induced apoptosis 7.08
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 7.05
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 6.98
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 6.76
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 6.76
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 6.75
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 6.71
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.7
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 6.69
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 6.66
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 6.66
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 6.44
The contribution of Alu exons to the human proteome 6.31
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 6.26
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 6.25
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 6.25
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 6.23
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 6.23
Defective structural RNA processing in relapsing-remitting multiple sclerosis 6.13
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 6.03
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 5.82
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 5.8
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 5.8
RNA polymerase in pre-B-ALL cell lines 5.78
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 5.74
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 5.62
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 5.61
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 5.61
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 5.61
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.61
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 5.5
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 5.49
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 5.46
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 5.44
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 5.32
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.16
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 5.16
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 5.14
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 5.09
The Genetic Landscape of Diamond-Blackfan Anemia 5.08
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 5.03
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 4.97
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 4.97
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 4.89
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 4.88
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 4.84
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 4.82
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 4.76
Gene expression profile of multiple myeloma cell lines treated with CB-5083 4.75
A novel target of EZH1/2 for treatment of mantle cell lymphoma 4.72
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 4.69
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 4.69
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 4.66
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.64
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 4.61
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 4.61
RNA expression analysis upon JMJD1C depletion 4.61
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 4.58
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 4.53
Conservative alteration of chromosomal expression pattern across human solid tumor types 4.49
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 4.48
Interaction between mitoNEET and NAF-1 in cancer cells 4.46
Transcriptome of EBV-infected gastric cancer cell lines 4.46
The transcriptome effect of overexpressing EZH2 in MCF7 4.38
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 4.29
Generation and functional characterization of MDSC-like cells 4.28
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 4.27
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 4.27
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.26
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 4.19
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 4.17
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 4.14
Human Treg NaCl stimulation 3.96
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 3.88
Common inflammatory pathways between NEC and Crohn's disease 3.77
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 3.76
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.75
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 3.74
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 3.74
Gene expression profile in breast cancer cell lines using RNA sequencing 3.65
Identification of renal resident macrophages across species [C1] 3.64
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 3.63
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 3.61
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 3.55
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 3.43
Identification of renal resident macrophages across species 3.42
RNA-seq analysis of control and Myc-induced U2OS cells 3.41
Gene profiling of human adult and pediatric liver cancer cells 3.35
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 3.28
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.26
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.14
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.14
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 3.03
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 2.99
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.98
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.87
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.87
RNA-sequencing of healthy human skeletal myocytes 2.85
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 2.81
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 2.75
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.71
Human Tfh cell RNA bulk sequencing 2.65
BMS-470539 on human synovial fibroblasts 2.63
BACH2 in human plasma cell fate decision 2.58
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.44
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 2.43
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 2.36
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 2.34
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.33
Transcriptome-wide response to synthetic chromatin protein PcTF 2.33
Next Generation Sequencing of human SMA and healthy control Motor Neurons 2.31
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 2.19
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.11
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.11
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.02
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.01
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.93
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.86
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.86
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.81
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.8
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.8
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 1.8
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.79
CD74 role in transcription regulation [RNA-seq] 1.79
CD74 role in transcription regulation 1.79
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.77
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 1.64
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.6
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.6
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.6
Transcriptome analysis of peripheral blood monocytes 1.55
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 1.54
Transcriptome analysis of CNS leukemia 1.47
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.47
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.47
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.4
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.37
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.31
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 1.29
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 1.29
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.28
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.2
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.2
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.13
Transcriptomes in healthy and CHB fetal hearts 1.11
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.11
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 1.1
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.06
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 1.04
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.99
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 0.99
Transcription elongation regulates genome 3D structure 0.84
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.78
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.78
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.75
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.74
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.72
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.71
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.65
RNAseq of Breast cancer PDX samples 0.6
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.53
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.53
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 0.48
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.48
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.48
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 0.44
HBEC-shp53-PCHD7 0.4
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.38
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 0.32
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.31
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.27
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 0.24
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.2
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 0.19
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.14
Transcriptomic analysis of human macrophages in 3D 0.14
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.1
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.1
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.08
Preclinical model of obesity and ER-positive breast cancer 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation